All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know ALL.
Certain subtypes of acute lymphoblastic leukemia (ALL) can be further distinguished by abnormalities in the karyotype that are detected using methods of cytogenetic analysis. Based on chromosomal aberrations, classifications such as Philadelphia chromosome-positive ALL, hyperdiploidy, and KMT2A/MLL allow to assess risk of relapse and can provide the basis for treatment decisions.